Chesapeake IRB Announces Acquisition of MaGil IRB

Published on: 

Applied Clinical Trials

Chesapeake IRB-technology-enabled independent institutional review board (IRB) that serves the clinical research industry-has acquired MaGil IRB.

The acquisition provides Chesapeake with additional AAHRPP-accredited review capacity and more staff, broadening its precense for CROs, pharma companes, and biotech companies.


Read the full release here.